Protillion Biosciences Raises $18M in Series A Financing
- Protillion Biosciences, a Burlingame, CA-based biotech company, raised $18M in Series A funding
- The round was led by ARCH Venture Partners and Illumina Ventures
- The company intends to use the funds to scale its hardware infrastructure and development teams
- ProtillionBiosciences is a Stanford University spinout commercializing technology for therapeutic antibody and binder discovery
- The company’s platform enables its commercial drug discovery partners to perform quantitative analysis on complete protein libraries, producing actionable insights in days
